MicroRNAs in Cardiac Diseases
- PMID: 31323768
- PMCID: PMC6678080
- DOI: 10.3390/cells8070737
MicroRNAs in Cardiac Diseases
Abstract
Since their discovery 20 years ago, microRNAs have been related to posttranscriptional regulation of gene expression in major cardiac physiological and pathological processes. We know now that cardiac muscle phenotypes are tightly regulated by multiple noncoding RNA species to maintain cardiac homeostasis. Upon stress or various pathological conditions, this class of non-coding RNAs has been found to modulate different cardiac pathological conditions, such as contractility, arrhythmia, myocardial infarction, hypertrophy, and inherited cardiomyopathies. This review summarizes and updates microRNAs playing a role in the different processes underlying the pathogenic phenotypes of cardiac muscle and highlights their potential role as disease biomarkers and therapeutic targets.
Keywords: cardiac diseases; heart; inherited cardiomyopathies; miRNA.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S., Chiuve S.E., Cushman M., Delling F.N., Deo R., et al. Heart disease and stroke statistics - 2018 update: A report from the American Heart Association. Circulation. 2018;137:e467–e492. doi: 10.1161/CIR.0000000000000558. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
